A polymorphism of NADPH oxidase p22 phox is associated with reduced susceptibility to acute rejection in renal allograft recipients

Transplant Immunology

Volumn 25, Issue 1, 2011, Pages 16-19

  Bhandary, U V ^a   Shirodkar, B ^a   Tse, W ^a   Hodgkinson, A D ^a   Demaine, A G ^a  

^a UNIVERSITY OF PLYMOUTH   (United Kingdom)

Author keywords

Allograft; NADPH; Oxidase; Polymorphism; Rejection; Superoxide

Indexed keywords

GENOMIC DNA; NADPH OXIDASE P22 PHOX PROTEIN; PLASMA PROTEIN; PROTEIN SUBUNIT; UNCLASSIFIED DRUG;

ACUTE GRAFT REJECTION; ANIMAL TISSUE; ARTICLE; CAUCASIAN; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DNA EXTRACTION; ENZYME ACTIVITY; FEMALE; GENE FREQUENCY; GENOTYPE; GRAFT RECIPIENT; HUMAN; KIDNEY ALLOGRAFT REJECTION; KIDNEY BIOPSY; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ALLELES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GRAFT REJECTION; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; NADPH OXIDASE; POLYMORPHISM, SINGLE NUCLEOTIDE; TRANSPLANTATION, HOMOLOGOUS;

EID: 79959684254     PISSN: 09663274     EISSN: 18785492     Source Type: Journal    
DOI: 10.1016/j.trim.2011.05.005     Document Type: Article

References (27)

1. Almond P.S., Matas A., Gillingham K., et al. Risk factors for chronic rejection in renal allograft recipients. Transplantation 1993, 55:752-757.
2. Halloran P.F., Melk A., Barth C. Rethinking chronic allograft nephropathy: the concept of accelerated senescence. J Am Soc Nephrol 1999, 10:167-181.
3. Hehner S.P., Breitkreutz R., Shubinsky G., et al. Enhancement of T cell receptor signaling by a mild oxidative shift in the intracellular thiol pool. J Immunol 2000, 165:4319-4328.
4. Los M., Droge W., Stricker K., et al. Hydrogen peroxide as a potent activator of T lymphocyte functions. Eur J Immunol 1995, 25:159-165.
5. Dalton T.P., Shertzer H.G., Puga A. Regulation of gene expression by reactive oxygen. Annu Rev Pharmacol Toxicol 1999, 39:67-101.
6. Shaulian E., Karin M. AP-1 in cell proliferation and survival. Oncogene 2001, 20:2390-2400.
7. Babior B.M. NADPH oxidase: an update. Blood 1999, 93:1464-1476. 1999.
8. Batot G., Martel C., Capdeville N., et al. Characterization of neutrophil NADPH oxidase activity reconstituted in a cell-free assay using specific monoclonal antibodies raised against cytochrome b558. Eur J Biochem 1995, 234:208-215.
9. Brozna J.P., Hauff N.F., Phillips W.A., et al. Activation of the respiratory burst in macrophages. Phosphorylation specifically associated with Fc receptor-mediated stimulation. J Immunol 1988, 141:1642-1647.
10. Banfi B., Molnar G., Maturana A., et al. A Ca(2+)-activated NADPH oxidase in testis, spleen, and lymph nodes. J Biol Chem 2001, 276:37594-37601.
11. Jones S.A., O'Donnell V.B., Wood J.D., et al. Expression of phagocyte NADPH oxidase components in human endothelial cells. Am J Physiol 1996, 271:H1626-H1634.
12. Inoue N., Kawashima S., Kanazawa K., et al. Polymorphism of the NADH/NADPH oxidase p22 phox gene in patients with coronary artery disease. Circulation 1998, 97:135-137.
13. Guzik T.J., West N.E., Black E., et al. Functional effect of the C242T polymorphism in the NAD(P)H oxidase p22phox gene on vascular superoxide production in atherosclerosis. Circulation 2000, 102:1744-1747.
14. Ito D., Murata M., Watanabe K., et al. C242T polymorphism of NADPH oxidase p22 PHOX gene and ischemic cerebrovascular disease in the Japanese population. Stroke 2000, 25:159-165.
15. San José G., Moreno M.U., Oliván S., et al. Functional effect of the p22phox -930A/G polymorphism on p22phox expression and NADPH oxidase activity in hypertension. Hypertension 2004, 44:163-169.
16. Miller S.A., Dykes D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988, 16:1215.
17. Solez K., Axelsen R.A., Benediktsson H., et al. International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int 1993, 44:411-422.
18. Perianayagam M.C., Liangos O., Kolyada A.Y., et al. NADPH oxidase p22phox and catalase gene variants are associated with biomarkers of oxidative stress and adverse outcomes in acute renal failure. J Am Soc Nephrol 2007, 18:255-263.
19. Modlinger P.S., Wilcox C.S., Aslam S. Nitric oxide, oxidative stress, and progression of chronic renal failure. Semin Nephrol 2004, 24:354-365.
20. Canbolat O., Fandrey J., Jelkmann W. Effects of modulators of the production and degradation of hydrogen peroxide on erythropoietin synthesis. Respir Physiol 1998, 114:175-183.
21. Irani K. Oxidant signaling in vascular cell growth, death, and survival: a review of the roles of reactive oxygen species in smooth muscle and endothelial cell mitogenic and apoptotic signaling. Circ Res 2000, 87:179-183.
22. Burke T.M., Wolin M.S. Hydrogen peroxide elicits pulmonary arterial relaxation and guanylate cyclase activation. Am J Physiol 1987, 252:H721-H732.
23. Cuzzocrea S., Pisano B., Dugo L., et al. Superoxide-related signaling cascade mediates nuclear factor-kappaB activation in acute inflammation. Antioxid Redox Signal 2004, 6:699-704.
24. Janssen Y.M., Matalon S., Mossman B.T. Differential induction of c-fos, c-jun, and apoptosis in lung epithelial cells exposed to ROS or RNS. Am J Physiol 1997, 273:L789-L796.
25. Hauser I.A., Riess R., Hausknecht B., et al. Expression of cell adhesion molecules in primary renal disease and renal allograft rejection. Nephrol Dial Transplant 1997, 12:1122-1131.
26. Sellak H., Franzini E., Hakim J., et al. Reactive oxygen species rapidly increase endothelial ICAM-1 ability to bind neutrophils without detectable upregulation. Blood 1994, 83:2669-2677.
27. Hoffmann S., Park J., Jacobson L.M., et al. Donor genomics influence graft events: the effect of donor polymorphisms on acute rejection and chronic allograft nephropathy. Kidney Int 2004, 66:1686-1693.